Abstract:Multiple biological barriers in solid tumors severely restrict the penetration of nanomedicines, which is a main cause for therapeutic failure in traditional tumor treatment. Here, a tumor-specific nanogenerator of peroxynitrite (ONOO–), prepared by loading cisplatin and sodium nitroprusside into poly(d,l-lactide-co-glycolide) polymersomes, was designed to improve drug delivery and enhance tumor chemotherapy. After a cascade of nicotinamide adenine dinucleotide phosphate oxidases catalysis and glutathione reduction, the nanogenerator, namely, PMCS, could selectively induce the generation of ONOO– in tumor. The generated ONOO– could not only strengthen vascular permeability significantly but also improve the accumulation and penetration of PMCS in tumor by activating matrix metalloproteinases-mediated degradation of extracellular matrix. Along with endocytosis, PMCS released cisplatin to induce tumor cell apoptosis. Moreover, free cisplatin liberated from dead cells infected neighboring tumor cells quickly via ONOO–-mediated up-regulated copper transporter 1, further amplifying chemotherapeutic efficacy. This study advances ONOO– as a potent modality to address the main issues of therapeutic delivery, including but not limited to chemotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c01312?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c01312</a>.Figures of TEM images, hydrodynamic size, DLS profiles, release of SNP, release of CDDP, hemolysis assay, superoxide anion generation, release of NO, representative CLSM images, flow cytometric analysis, mean fluorescence intensity, relative CDDP endocytosis, Trypan blue staining, intracellular ATP levels, blood circulation curve, DAX-J2 PON green staining, immunofluorescent staining, activity analysis, in vivo fluorescence imaging, mean fluorescence intensity values, tumor volume change, body weight change, H&E staining, and survival curves and tables of blood routine examination and blood biochemical analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c01312/suppl_file/nn1c01312_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Record‐High Ultrasound‐Sensitive NO Nanogenerators for Cascade Tumor Pyroptosis and Immunotherapy

Near-Infrared Light-Triggered Nitric Oxide Nanogenerators for NO-Photothermal Synergistic Cancer Therapy

Self-modifying NanoEnhancers Facilitating Lysosomal Escape for Cgas-Sting Cascading Activation in Tumor Immunotherapy

Novel 131-iodine labeled and ultrasound-responsive nitric oxide and reactive oxygen species controlled released nanoplatform for synergistic sonodynamic/nitric oxide/chemodynamic/radionuclide therapy

Low dose soft X-ray-controlled deep-tissue long-lasting NO release of persistent luminescence nanoplatform for gas-sensitized anticancer therapy

Intracellular NO-Generator Based on Enzyme Trigger for Localized Tumor-Cytoplasm Rapid Drug Release and Synergetic Cancer Therapy

Near‐Infrared Laser‐Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer

A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia

Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy

Photothermal-controlled NO-releasing Nanogels reverse epithelial-mesenchymal transition and restore immune surveillance against cancer metastasis

Bionanoparticles with In Situ Nitric Oxide Release for Precise Modulation of ER‐TRPV1 Ion Channels in Multimodal Killing of Glioblastoma

Near‐infrared Light‐responsive Nitric Oxide Microcarrier for Multimodal Tumor Therapy (3/2023)

Ultrasound-Induced Piezocatalysis Triggered NO Generation for Enhanced Hypoxic Tumor Therapy

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment

Tumor-Specific ONOO – Nanogenerator for Improved Drug Delivery and Enhanced Chemotherapy of Tumor

Programmed Nanoreactors Boost Immune Response through ROS Cascade Amplification along with RNS Storm

NIR-Triggered On-Demand Nitric Oxide Release for Enhanced Synergistic Phototherapy of Hypoxic Tumor

Engineering 2D Multienzyme‐Mimicking Pyroptosis Inducers for Ultrasound‐Augmented Catalytic Tumor Nanotherapy

Light‐Triggered Nitric Oxide Nanogenerator with High L‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy

A Cascade-Amplified Pyroptosis Inducer: Optimizing Oxidative Stress Microenvironment by Self-Supplying Reactive Nitrogen Species Enables Potent Cancer Immunotherapy

Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation